-
Maraviroc, sold
under the
brand names Selzentry (US) and
Celsentri (EU), is an
antiretroviral medication used to
treat HIV infection. It is
taken by mouth...
- and
Pfizer with
maraviroc.[citation needed] All of the
compounds reached clinical trials in humans;[citation needed] only
maraviroc has been approved[vague]...
- Vicriviroc,
similar to
maraviroc, is
currently undergoing clinical trials for FDA approval. Aplaviroc, an
agent similar to
maraviroc and vicriroc. Clinical...
- Plough),
Aplaviroc (GW-873140) (GlaxoSmithKline) and
Maraviroc (UK-427857) (Pfizer).
Maraviroc was
approved for use by the FDA in
August 2007. It is...
-
Stavudine (d4T)
Etravirine Fosamprenavir Indinavir Lamivudine (3TC)
Lopinavir Maraviroc Nelfinavir Nevirapine Raltegravir Ritonavir Saquinavir Tenofovir Tipranavir...
-
blocking one of
several targets.
Maraviroc,
enfuvirtide and
Ibalizumab are
available agents in this class.
Maraviroc works by
targeting CCR5, a co-receptor...
-
negative allosteric modulators (NAM)
lower agonist affinity and/or efficacy.
Maraviroc is a
medicine that
modulates CCR5. Fenobam,
raseglurant and dipraglurant...
-
Lexiva and Telzir)
nelfinavir (brand name Viracept)
Entry inhibitors:
maraviroc (brand
names Selzentry and Celsentri)
Antiretroviral fixed-dose combinations...
-
Letermovir (Prevymis)
Cytomegalovirus (CMV)
Lopinavir HIV
Loviride HIV
Maraviroc HIV
entry inhibitor Methisazone Smallpox Molnupiravir COVID-19
Merck &...
-
targets include the calcium-mimicking
cinacalcet and the HIV
treatment maraviroc.
Allosteric proteins are
involved in, and are
central in many diseases...
